Rigel Pharmaceuticals, Inc. (RIGL) Ownership

$16.60

south_east
-$0.78 (-4.49%)
Day's range
$16.53
Day's range
$17.67

Rigel Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK FUNDING, INC. /DE 02/07/2025 1.75 M $29.40 M   11.95% 9.93%
ARMISTICE CAPITAL, LLC 02/14/2025 1.15 M $19.38 M   -25.00% 6.55%
SOLEUS CAPITAL MANAGEMENT, L.P. 02/14/2025 1.13 M $19.02 M   20.96% 6.42%
ASSENAGON ASSET MANAGEMENT S.A. 01/14/2025 410,778 $6.91 M   -7.01% 2.33%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 376,366 $6.33 M   -10.77% 2.14%
CM MANAGEMENT, LLC 02/07/2025 242,500 $4.08 M   -16.38% 1.38%
HILLSDALE INVESTMENT MANAGEMENT INC. 02/11/2025 170,100 $2.86 M   814.52% 0.97%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2025 139,128 $2.34 M   41.96% 0.79%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 117,957 $1.98 M   100.00% 0.67%
DLD ASSET MANAGEMENT, LP 02/12/2025 100,000 $28,010   100.00% 0.57%
LOS ANGELES CAPITAL MANAGEMENT LLC 02/04/2025 86,001 $1.45 M   15.43% 0.49%
ENSIGN PEAK ADVISORS, INC 02/14/2025 85,878 $1.44 M   100.00% 0.49%
ZACKS INVESTMENT MANAGEMENT 02/13/2025 85,423 $1.44 M   100.00% 0.49%
UBS OCONNOR LLC 02/14/2025 84,311 $1.42 M   -27.89% 0.48%
STATE OF WISCONSIN INVESTMENT BOARD 02/14/2025 72,451 $1.22 M   151.04% 0.41%
HRT FINANCIAL LP 02/14/2025 68,191 $1.15 M   100.00% 0.39%
SQUAREPOINT OPS LLC 02/14/2025 63,416 $1.07 M   40.12% 0.36%
GLOBEFLEX CAPITAL L P 02/10/2025 52,295 $879,602   468.42% 0.30%
TREXQUANT INVESTMENT LP 02/12/2025 44,171 $742,956   100.00% 0.25%
02/28/2025 40,200 $676,164   100.00% 0.23%
SEGALL BRYANT & HAMILL, LLC 02/11/2025 36,259 $609,876   100.00% 0.21%
LAZARD ASSET MANAGEMENT LLC 02/14/2025 30,840 $518,000   54.11% 0.18%
JUMP FINANCIAL, LLC 02/13/2025 30,035 $505,189   96.50% 0.17%
02/10/2025 23,700 $398,634   777.78% 0.13%
FRANKLIN RESOURCES INC 02/12/2025 21,809 $366,828   70.84% 0.12%
WALLEYE CAPITAL LLC 02/13/2025 21,621 $363,665   100.00% 0.12%
NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN 02/06/2025 20,000 $336,400   0.00% 0.11%
PDT PARTNERS, LLC 02/14/2025 19,829 $333,524   -0.43% 0.11%
MAN GROUP PLC 02/14/2025 18,156 $305,384   -29.07% 0.10%
VERITION FUND MANAGEMENT LLC 02/14/2025 15,953 $268,329   100.00% 0.09%
EXODUSPOINT CAPITAL MANAGEMENT, LP 02/12/2025 15,483 $260,000   100.00% 0.09%
ALPS ADVISORS INC 02/13/2025 14,240 $239,517   100.00% 0.08%
KENNEDY CAPITAL MANAGEMENT LLC 02/13/2025 13,418 $225,691   -85.81% 0.08%
ENGINEERS GATE MANAGER LP 02/14/2025 12,609 $212,083   100.00% 0.07%
EMPIRE FINANCIAL MANAGEMENT COMPANY, LLC 02/14/2025 12,000 $201,840   -15.79% 0.07%
CONNECTICUT WEALTH MANAGEMENT, LLC 02/18/2025 11,520 $193,766   0.00% 0.07%
SHERBROOKE PARK ADVISERS LLC 02/14/2025 11,075 $186,282   100.00% 0.06%
XTX TOPCO LTD 02/13/2025 10,910 $183,506   100.00% 0.06%
02/13/2025 10,759 $180,966   100.00% 0.06%
GRAHAM CAPITAL MANAGEMENT, L.P. 02/14/2025 10,086 $169,647   100.00% 0.06%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 9,902 $166,552   2.89% 0.06%
COREBRIDGE FINANCIAL, INC. 02/11/2025 8,653 $145,543   -7.03% 0.05%
02/11/2025 5,056 $85,042   100.00% 0.03%
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. 01/24/2025 3,735 $62,823   100.00% 0.02%
PICTON MAHONEY ASSET MANAGEMENT 02/10/2025 1,297 $22,000   2.05% 0.01%
FARTHER FINANCE ADVISORS, LLC 02/10/2025 667 $11,219   0.00% 0.00%
AMALGAMATED BANK 02/04/2025 588 $10,000   0.00% 0.00%
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. 01/27/2025 587 $9,686   100.00% 0.00%
CULLEN/FROST BANKERS, INC. 02/06/2025 402 $6,762   100.00% 0.00%
02/19/2025 370 $6,223   100.00% 0.00%

Rigel Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 114 institutional investors and hedge funds held shares of Rigel Pharmaceuticals, Inc.. The most heavily invested institutionals were:

BlackRock Funding, Inc. /DE: 1.75 M

ARMISTICE CAPITAL, LLC: 1.15 M

Soleus Capital Management, L.P.: 1.13 M

Assenagon Asset Management S.A.: 410,778

ACADIAN ASSET MANAGEMENT LLC: 376,366

CM Management, LLC: 242,500

68.52% of Rigel Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 23.15 M shares in the last 24 months. This purchase volume represents approximately $384.32 M in transactions.